• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子建模研究设计为潜在抗恰加斯病和抗利什曼病前药的树枝状聚合物的解体。

Molecular modeling study on the disassembly of dendrimers designed as potential antichagasic and antileishmanial prodrugs.

机构信息

LAPEN, Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo (USP), São Paulo, SP, Brazil.

出版信息

J Mol Model. 2012 May;18(5):2257-69. doi: 10.1007/s00894-011-1244-8. Epub 2011 Oct 2.

DOI:10.1007/s00894-011-1244-8
PMID:21965079
Abstract

A molecular modeling study was carried out to investigate the most likely enzymatic disassembly mechanism of dendrimers that were designed as potential antichagasic and antileishmanial prodrugs. The models contained myo-inositol (core), L-malic acid (spacer), and active agents such as 3-hydroxyflavone, quercetin, and hydroxymethylnitrofurazone (NFOH). A theoretical approach that considered one, two, or three branches has already been performed and reported by our research group; the work described herein focused on four (models A and B), five, or six branches, and considered their physicochemical properties, such as spatial hindrance, electrostatic potential mapping, and the lowest unoccupied molecular orbital energy (E(LUMO)). The findings suggest that the carbonyl group next to the myo-inositol is the most promising ester breaking point.

摘要

进行了分子建模研究,以调查作为潜在抗恰加斯病和抗利什曼病前药设计的树枝状分子最可能的酶促分解机制。模型包含肌醇(核心)、L-苹果酸(间隔物)和 3-羟基黄酮、槲皮素和羟甲基硝基呋喃酮(NFOH)等活性物质。我们的研究小组已经进行并报告了一种、两种或三种支链的理论方法;本文所述的工作集中在四个(模型 A 和 B)、五个或六个支链,并考虑了它们的物理化学性质,如空间阻碍、静电势映射和最低未占据分子轨道能量 (E(LUMO))。研究结果表明,肌醇旁边的羰基是最有希望的酯断裂点。

相似文献

1
Molecular modeling study on the disassembly of dendrimers designed as potential antichagasic and antileishmanial prodrugs.分子建模研究设计为潜在抗恰加斯病和抗利什曼病前药的树枝状聚合物的解体。
J Mol Model. 2012 May;18(5):2257-69. doi: 10.1007/s00894-011-1244-8. Epub 2011 Oct 2.
2
Design and exploratory data analysis of a second generation of dendrimer prodrugs potentially antichagasic and leishmanicide.第二代树枝状前药的设计和探索性数据分析,具有抗恰加斯病和利什曼病的潜力。
Mol Divers. 2013 Nov;17(4):711-20. doi: 10.1007/s11030-013-9467-5. Epub 2013 Aug 29.
3
Synthesis and in vitro evaluation of potential antichagasic hydroxymethylnitrofurazone (NFOH-121): a new nitrofurazone prodrug.潜在抗恰加斯病药物羟甲基硝呋腙(NFOH-121)的合成及体外评价:一种新型硝呋腙前药
Bioorg Med Chem. 2003 Nov 3;11(22):4779-83. doi: 10.1016/j.bmc.2003.07.004.
4
Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi.羟甲基硝呋酮和硝呋酮对克氏锥虫的抑制作用:对一种新的靶标的研究。
J Enzyme Inhib Med Chem. 2010 Feb;25(1):62-7. doi: 10.3109/14756360902941058.
5
Pharmacokinetics of hydroxymethylnitrofurazone, a promising new prodrug for Chagas' disease treatment.羟甲基硝基呋喃腙的药代动力学,一种有望用于治疗恰加斯病的新型前体药物。
Antimicrob Agents Chemother. 2013 Dec;57(12):6106-9. doi: 10.1128/AAC.02522-12. Epub 2013 Sep 30.
6
Pharmacokinetics of hydroxymethylnitrofurazone and its parent drug nitrofurazone in rabbits.羟甲基呋喃西林及其母体药物呋喃西林在兔体内的药代动力学
Drug Metab Lett. 2013 Mar;7(1):58-64. doi: 10.2174/18723128112069990013.
7
Rapid test for the evaluation of the activity of the prodrug hydroxymethylnitrofurazone in the processing of Trypanosoma cruzi messenger RNAs.用于评估前药羟甲基硝基呋喃腙在克氏锥虫信使核糖核酸加工过程中活性的快速检测方法。
Braz J Med Biol Res. 2007 Jan;40(1):33-9. doi: 10.1590/s0100-879x2007000100005.
8
CoMFA-SIMCA model for antichagasic nitrofurazone derivatives.用于抗恰加斯病硝呋替莫衍生物的比较分子场分析-软独立建模类比法模型
Bioorg Med Chem. 2001 Apr;9(4):1025-30. doi: 10.1016/s0968-0896(00)00320-5.
9
Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry.第二代树枝状前药的酶促激活:通过点击化学将自毁型树枝状大分子与聚乙二醇共轭。
Bioconjug Chem. 2006 Nov-Dec;17(6):1432-40. doi: 10.1021/bc060180n.
10
Design, synthesis, and evaluation of potential prodrugs of DFMO for reductive activation.设计、合成和评估潜在的 DFMO 前药用于还原激活。
Bioorg Med Chem Lett. 2012 Nov 1;22(21):6583-6. doi: 10.1016/j.bmcl.2012.09.005. Epub 2012 Sep 13.

引用本文的文献

1
Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties.药物/先导化合物羟甲基化:一种增强药效学和药代动力学性质的简单方法
Front Chem. 2022 Feb 14;9:734983. doi: 10.3389/fchem.2021.734983. eCollection 2021.
2
Intracellular Iron Binding and Antioxidant Activity of Phytochelators.植物螯合肽的细胞内铁结合和抗氧化活性。
Biol Trace Elem Res. 2022 Aug;200(8):3910-3918. doi: 10.1007/s12011-021-02965-y. Epub 2021 Oct 14.
3
Dendrimer Prodrugs.树枝状聚合物前药

本文引用的文献

1
Chagas disease: a new worldwide challenge.恰加斯病:一项新的全球挑战。
Nature. 2010 Jun 24;465(7301):S6-7. doi: 10.1038/nature09221.
2
Chagas disease 101.恰加斯病入门知识。
Nature. 2010 Jun 24;465(7301):S4-5. doi: 10.1038/nature09220.
3
Chagas disease: pushing through the pipeline.恰加斯病:推进研发进程
Molecules. 2016 May 31;21(6):686. doi: 10.3390/molecules21060686.
Nature. 2010 Jun 24;465(7301):S12-5. doi: 10.1038/nature09224.
4
Hydroxymethylnitrofurazone is active in a murine model of Chagas' disease.羟甲基硝基呋喃酮在恰加斯病的小鼠模型中具有活性。
Antimicrob Agents Chemother. 2010 Sep;54(9):3584-9. doi: 10.1128/AAC.01451-09. Epub 2010 Jun 21.
5
Neglected tropical diseases in Brazil.巴西的被忽视热带病。
Rev Inst Med Trop Sao Paulo. 2009 Sep-Oct;51(5):247-53. doi: 10.1590/s0036-46652009000500003.
6
Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery.恰加斯病的流行病学、控制和监测:发现 100 年后。
Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:31-40. doi: 10.1590/s0074-02762009000900006.
7
Leishmaniasis.利什曼病
J Dtsch Dermatol Ges. 2008 Sep;6(9):754-65. doi: 10.1111/j.1610-0387.2008.06809.x.
8
Dendrimers as versatile platform in drug delivery applications.树枝状大分子作为药物递送应用中的多功能平台。
Eur J Pharm Biopharm. 2009 Mar;71(3):445-62. doi: 10.1016/j.ejpb.2008.09.023. Epub 2008 Oct 17.
9
Prodrugs for the treatment of neglected diseases.用于治疗被忽视疾病的前体药物。
Molecules. 2007 Mar 19;13(3):616-77. doi: 10.3390/molecules13030616.
10
Leishmaniasis treatment--a challenge that remains: a review.利什曼病的治疗——一项仍具挑战性的任务:综述
Parasitol Res. 2008 Jun;103(1):1-10. doi: 10.1007/s00436-008-0943-2.